Peptica
Direct comparison

Semaglutid vs Mazdutid

Metabolism
Semaglutid
GLP-1 analog
clinically establishedvs
Metabolism
Mazdutid
GLP-1 analog
early clinical studies
SemaglutidMazdutid
Class
GLP-1 analog
GLP-1 analog
Mechanism
Semaglutide is a synthetic analog of the body's own incretin hormone GLP-1 (glucagon-like peptide-1).
Mazdutide is a dual agonist at GLP-1 and glucagon receptors, derived from oxyntomodulin (OXM).
Studied effects
Metabolism
Metabolism
Evidence level
clinically established
early clinical studies
Legal status (DE)
prescription-only
not approved
WADA-listed
No
No
Half-life
~7 days
~6 days (once weekly)
Studies cited
3
2
Sourcing & partnersAd
europeptidesPEPTICA

europeptides

Visit partner →
unyxpeptides

unyxpeptides

Visit partner →
clearpeptidesPeptica

clearpeptides

Visit partner →

Partner / affiliate links — Peptica may earn a commission. No endorsement; not medical advice. Peptica sells no substances.

Related comparisons
Semaglutid vs TirzepatidSemaglutid vs RetatrutidSemaglutid vs CagrilintidTirzepatid vs Mazdutid
Important notice

This site is intended solely for factual, scientifically oriented information about peptides. It does not constitute medical advice, does not replace a consultation with a doctor and contains no recommendations for use in humans. Peptica sells no substances and names no sources for unapproved substances.